Vimarsana
Biggest News Aggregation in the World

Active Pharma Ingredients News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Active Pharma Ingredients. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Active Pharma Ingredients Today - Breaking & Trending Today

LIC: LIC News, Life Insurance Corporation of India Latest Updates - Vimarsana News

LIC: LIC News, Life Insurance Corporation of India Latest Updates

LIC: LIC News, latest updates. Read all about LIC (Life Insurance Corporation) on the Economic Times. Get details of How to check LIC Premium Status, lic policy list, details & benefits

lic: LIC sells over 2% stake in Sun Pharma for Rs 4,699 crore - Vimarsana News

lic: LIC sells over 2% stake in Sun Pharma for Rs 4,699 crore

The shares were sold at an average price of Rs 973.80 per share during the period through an open market sale in an ordinary course of transaction, it said. Sun Pharma is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APls).

Granules India down over 4% as Q1 profit declines - Vimarsana News

Granules India down over 4% as Q1 profit declines

Granules India’s net profit tanked 62.4 percent YoY to Rs 47.9 crore.

shares to buy: Breakout looms in large-cap pharma stock as oil major goes sideways - Vimarsana News

shares to buy: Breakout looms in large-cap pharma stock as oil major goes sideways

The stock price of this company had bottomed out in May and formed a higher low, thereafter. Now it has given a trendline-resistance breakout on a closing basis. The candle formed can be considered a bullish Marubozu. The surge in volume over the past few sessions is supportive of the breakout. The stock is expected to be propelled higher and to challenge its previous peak.

Eiko Lifesciences touches roof on inking pact to acquire 25.01% stake in Reflux Pharmaceuticals - Vimarsana News

Eiko Lifesciences touches roof on inking pact to acquire 25.01% stake in Reflux Pharmaceuticals

Eiko Lifesciences is currently trading at upper circuit limit of Rs. 74.60, up by 3.55 points or 5.00% from its previous closing of Rs. 71.05 on the BSE. The scrip opened at Rs. 73.98 and has touched a high and low of Rs. 74.60 and Rs. 73.00 respectively. So far 58227 shares were traded on